AMGEN INC 4663 Profile

031162CF5   86.12  0.31  0.36%   

Performance

Very Weak

 
Weak
 
Strong

Odds Of Default

Below Average

 
High
 
Low
AMGEN is trading at 86.12 as of the 21st of March 2025, a 0.36% down since the beginning of the trading day. The bond's open price was 86.43. AMGEN has about a 41 percent probability of financial distress in the next few years of operation and has generated negative returns over the last 90 days. Ratings for AMGEN INC 4663 are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 21st of December 2024 and ending today, the 21st of March 2025. Click here to learn more.

Moving together with AMGEN Bond

  0.65CDR-PB Cedar Realty TrustPairCorr
  0.66NVRO Nevro CorpPairCorr

AMGEN Bond Highlights

Business ConcentrationAMGEN INC 4663 Corporate Bond, Industrial, Manufacturing (View all Sectors)
AMGEN INC 4663 (031162CF5) is traded in USA.

AMGEN INC 4663 Risk Profiles

AMGEN Against Markets

Be your own money manager

Our tools can tell you how much better you can do entering a position in AMGEN without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Equity Analysis Now

   

Equity Analysis

Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
All  Next Launch Module

Other Information on Investing in AMGEN Bond

AMGEN financial ratios help investors to determine whether AMGEN Bond is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in AMGEN with respect to the benefits of owning AMGEN security.